130 related articles for article (PubMed ID: 10703692)
41. Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis.
Duncan SR; Leonard C; Theodore J; Lega M; Girgis RE; Rosen GD; Theofilopoulos AN
Am J Respir Crit Care Med; 2002 May; 165(10):1439-44. PubMed ID: 12016109
[TBL] [Abstract][Full Text] [Related]
42. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.
Scholma J; Slebos DJ; Boezen HM; van den Berg JW; van der Bij W; de Boer WJ; Koëter GH; Timens W; Kauffman HF; Postma DS
Am J Respir Crit Care Med; 2000 Dec; 162(6):2221-5. PubMed ID: 11112142
[TBL] [Abstract][Full Text] [Related]
43. Nitric oxide in the development of obliterative bronchiolitis in a heterotopic pig model.
Salminen US; Maasilta PK; Harjula AL; Romanska HM; Bishop AE; Polak JM
Transplantation; 2002 Jun; 73(11):1724-9. PubMed ID: 12084993
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells.
Jollow KC; Sundstrom JB; Gravanis MB; Kanter K; Herskowitz A; Ansari AA
Transplantation; 1997 May; 63(10):1482-9. PubMed ID: 9175814
[TBL] [Abstract][Full Text] [Related]
45. miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p.
Bozzini S; Pandolfi L; Rossi E; Inghilleri S; Zorzetto M; Ferrario G; Di Carlo S; Politano G; De Silvestri A; Frangipane V; Porzio M; Kessler R; Calabrese F; Meloni F; Morbini P
Cells; 2021 Mar; 10(3):. PubMed ID: 33804639
[TBL] [Abstract][Full Text] [Related]
46. Cromolyn ameliorates acute and chronic injury in a rat lung transplant model.
Chang JC; Leung J; Tang T; Holzknecht ZE; Hartwig MG; Duane Davis R; Parker W; Abraham SN; Lin SS
J Heart Lung Transplant; 2014 Jul; 33(7):749-57. PubMed ID: 24768366
[TBL] [Abstract][Full Text] [Related]
47. Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy.
Hutter JA; Stewart S; Higenbottam T; Scott JP; Wallwork J
J Heart Transplant; 1988; 7(6):440-4. PubMed ID: 3145335
[TBL] [Abstract][Full Text] [Related]
48. Significance of acute bronchitis/bronchiolitis in the lung transplant recipient.
Ohori NP; Iacono AT; Grgurich WF; Yousem SA
Am J Surg Pathol; 1994 Dec; 18(12):1192-204. PubMed ID: 7977942
[TBL] [Abstract][Full Text] [Related]
49. Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat.
Kallio EA; Koskinen PK; Aavik E; Buchdunger E; Lemström KB
Am J Respir Crit Care Med; 1999 Oct; 160(4):1324-32. PubMed ID: 10508825
[TBL] [Abstract][Full Text] [Related]
50. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.
Gupta PK; Wagner SR; Wu Q; Shilling RA
Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023
[TBL] [Abstract][Full Text] [Related]
51. The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation.
Sato M; Hirayama S; Hwang DM; Lara-Guerra H; Wagnetz D; Waddell TK; Liu M; Keshavjee S
J Immunol; 2009 Jun; 182(11):7307-16. PubMed ID: 19454728
[TBL] [Abstract][Full Text] [Related]
52. Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts.
Raissadati A; Nykänen AI; Tuuminen R; Syrjälä SO; Krebs R; Arnaudova R; Rouvinen E; Wang X; Poller W; Lemström KB
Transpl Int; 2015 Dec; 28(12):1416-25. PubMed ID: 26174800
[TBL] [Abstract][Full Text] [Related]
53. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link?
Wilkes DS
J Clin Invest; 2011 Jun; 121(6):2155-7. PubMed ID: 21606603
[TBL] [Abstract][Full Text] [Related]
54. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients.
Kshettry VR; Kroshus TJ; Savik K; Hertz MI; Bolman RM
Chest; 1996 Sep; 110(3):704-9. PubMed ID: 8797415
[TBL] [Abstract][Full Text] [Related]
55. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation.
Schulman LL; Weinberg AD; McGregor CC; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 2001 Feb; 163(2):437-42. PubMed ID: 11179119
[TBL] [Abstract][Full Text] [Related]
56. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
[TBL] [Abstract][Full Text] [Related]
57. A relevant experimental model for human bronchiolitis obliterans syndrome.
Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
[TBL] [Abstract][Full Text] [Related]
58. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
59. [Post-lung transplantation bronchiolitis obliterans].
Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
[TBL] [Abstract][Full Text] [Related]
60. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model.
King MB; Jessurun J; Savik SK; Murray JJ; Hertz MI
Transplantation; 1997 Feb; 63(4):528-32. PubMed ID: 9047145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
